Zomig (zolmitriptan) for migraines
October 1998
Pfizer is now marketing Zomig (zolmitriptan) for migraines.
It's the third "triptan" on the market...after sumatriptan (Imitrex) and naratriptan (Amerge).
Think of Zomig as similar to sumatriptan. They both have a fast onset and short duration of action.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive